Zydus Lifesciences LimitedNSE: ZYDUSLIFE

Press Release Mar 24 2021

· Issued by Zydus Lifesciences Limited

Filed with NSE ·

Cadila Healthcare Limited has informed the Exchange regarding a press release dated March 24, 2021, titled "Please find enclosed a copy of press release dated March 24, 2021 titled RemdacTM (Remdesivir) from Zydus now more affordable at Rs.899 .".

View Attachment

6ix hasn’t read this filing yet.

Zydus Lifesciences Limited on 6ix

Earlier from Zydus Lifesciences

Later from Zydus Lifesciences

All Zydus Lifesciences news releases